These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34885905)

  • 1. Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor.
    Meng X; Wang Y
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilobetin, a novel small molecule inhibitor targeting influenza virus polymerase acidic (PA) endonuclease was screened from plant extracts.
    Zhang J; Wang Y
    Nat Prod Res; 2021 Dec; 35(24):5968-5971. PubMed ID: 32820654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel inhibitor against endonuclease subunit of Influenza pH1N1 polymerase: A combined molecular docking, molecular dynamics, MMPBSA, QMMM and ADME studies to combat influenza A viruses.
    Mohseni SS; Nasri F; Davari K; Mirzaie S; Moradzadegan A; Abdi F; Farzaneh F
    Comput Biol Chem; 2018 Dec; 77():279-290. PubMed ID: 30396155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PA
    Liao Y; Ye Y; Li S; Zhuang Y; Chen L; Chen J; Cui Z; Huo L; Liu S; Song G
    Eur J Med Chem; 2020 Mar; 189():112048. PubMed ID: 31954881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors.
    Jones JC; Kumar G; Barman S; Najera I; White SW; Webby RJ; Govorkova EA
    mBio; 2018 Apr; 9(2):. PubMed ID: 29691337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
    Hickerson BT; Petrovskaya SN; Dickensheets H; Donnelly RP; Ince WL; Ilyushina NA
    J Virol; 2023 Jul; 97(7):e0015423. PubMed ID: 37404185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PA
    Liu Z; Gu S; Zhu X; Liu M; Cao Z; Qiu P; Li S; Liu S; Song G
    Eur J Med Chem; 2022 Jan; 227():113929. PubMed ID: 34700269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAR Exploration of Tight-Binding Inhibitors of Influenza Virus PA Endonuclease.
    Credille CV; Morrison CN; Stokes RW; Dick BL; Feng Y; Sun J; Chen Y; Cohen SM
    J Med Chem; 2019 Nov; 62(21):9438-9449. PubMed ID: 31536340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of an I38T amino acid substitution in influenza polymerase acidic subunit associated with reduced susceptibility to baloxavir marboxil.
    Nakauchi M; Takashita E; Fujisaki S; Shirakura M; Ogawa R; Morita H; Miura H; Saito S; Watanabe S; Odagiri T; Kageyama T
    Influenza Other Respir Viruses; 2020 Jul; 14(4):436-443. PubMed ID: 32064779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the 2,3-dihydroisoindole pharmacophore for inhibition of the influenza virus PA endonuclease.
    Rogolino D; Naesens L; Bartoli J; Carcelli M; De Luca L; Pelosi G; Stokes RW; Van Berwaer R; Vittorio S; Stevaert A; Cohen SM
    Bioorg Chem; 2021 Nov; 116():105388. PubMed ID: 34670331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor.
    Todd B; Tchesnokov EP; Götte M
    J Biol Chem; 2021; 296():100486. PubMed ID: 33647314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-influenza activity of c60 fullerene derivatives.
    Shoji M; Takahashi E; Hatakeyama D; Iwai Y; Morita Y; Shirayama R; Echigo N; Kido H; Nakamura S; Mashino T; Okutani T; Kuzuhara T
    PLoS One; 2013; 8(6):e66337. PubMed ID: 23785493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility.
    Jones JC; Pascua PNQ; Fabrizio TP; Marathe BM; Seiler P; Barman S; Webby RJ; Webster RG; Govorkova EA
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8593-8601. PubMed ID: 32217734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.
    Omoto S; Speranzini V; Hashimoto T; Noshi T; Yamaguchi H; Kawai M; Kawaguchi K; Uehara T; Shishido T; Naito A; Cusack S
    Sci Rep; 2018 Jun; 8(1):9633. PubMed ID: 29941893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Influenza PA
    Zhang C; Xiang J; Xie Q; Zhao J; Zhang H; Huang E; Shaw P; Liu X; Hu C
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir.
    Ivashchenko AA; Mitkin OD; Jones JC; Nikitin AV; Koryakova AG; Karapetian RN; Kravchenko DV; Mochalov SV; Ryakhovskiy AA; Aladinskiy V; Leneva IA; Falynskova IN; Glubokova EA; Govorkova EA; Ivachtchenko AV
    J Antimicrob Chemother; 2021 Mar; 76(4):1010-1018. PubMed ID: 33367751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Distinctive Binding Modes of Endonuclease Inhibitors to the N-Terminal Region of Influenza Virus Polymerase Acidic Subunit.
    Fudo S; Yamamoto N; Nukaga M; Odagiri T; Tashiro M; Hoshino T
    Biochemistry; 2016 May; 55(18):2646-60. PubMed ID: 27088785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.
    Ju H; Zhang J; Huang B; Kang D; Huang B; Liu X; Zhan P
    J Med Chem; 2017 May; 60(9):3533-3551. PubMed ID: 28118010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease.
    Beylkin D; Kumar G; Zhou W; Park J; Jeevan T; Lagisetti C; Harfoot R; Webby RJ; White SW; Webb TR
    Sci Rep; 2017 Dec; 7(1):17139. PubMed ID: 29215062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and In Vitro Evaluation of C-7 and C-8 Luteolin Derivatives as Influenza Endonuclease Inhibitors.
    Reiberger R; Radilová K; Kráľ M; Zima V; Majer P; Brynda J; Dračínský M; Konvalinka J; Kožíšek M; Machara A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.